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Background
Many calls have been made for vaccines that induce both
CTL and Nab but why this would be substantially more
effective, nor the path to achieve this, are unclear. HIV-1
Env is the only protein subject to both NAb and CTL pres-
sure. We hypothesized that serially escaping both Env-
specific CTL and NAb responses could have implications
for both viral fitness and the reversion of multiple muta-
tions upon transmission to naive hosts.
Methods
The impact and reversion of 3 well-define HIV-1 Env CTL
escape mutant SHIVmn229 viruses to wild-type following
in vivo passage experiments was studied in 6 pigtail
macaques. Through extensive sequencing we analyzed the
relationship between the reversion of CTL mutations with
adjacent N-linked glycosylation site (NLGS) mutations.
Env-pseudotype viruses were constructed expressing com-
binations of WT and EM mutations at both CTL and NLGS
sites and assessed for their susceptibility to autologous
Nab in sera.
Results
Env CTL mutations either did not revert to wild type or
only transiently reverted 5–7 weeks after infection. CTL
escape mutant reversion was however coincident, on pre-
cisely the same viral clones, with loss of adjacent NLGS
mutations, suggesting strong clonal links at viruses adapt-
ing to both immune pressures. At one site studied in
detail, both CTL and NLGS mutations were needed to
confer Nab early escape, with the NLGS mutations alone
insufficient to confer full Nab escape.
Conclusion
We conclude CTL and NAb escape within Env can be
tightly linked, reflecting remarkably flexibility in viral
adaptation to multiple coincident immune pressures.
Although fitness costs of individual Env-specific CTL and
Nab escape mutations may not be substantial, we specu-
late that there may yet be opportunities to identify and
target linked combinations of cellular and humoral
immunity to Env that are more difficult to simultaneously
escape without substantial fitness costs.
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